Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias

Wilbert S. Aronow, Chul Ahn, Anthony D. Mercando, Stanley Epstein

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Sudden cardiac death and acute myocardial infarction have a circadian pattern with a significant morning peak.1-6 The circadian rhythm associated with acute myocardial infarction was not observed in patients receiving propranolol.6 We are reporting data on the times of sudden cardiac death or fatal myocardial infarction from a prospective study of patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and a left ventricular ejection fraction ≥40% randomized to propranolol or no antiarrhythmic drug.7.

Original languageEnglish (US)
Pages (from-to)819-821
Number of pages3
JournalThe American Journal of Cardiology
Volume74
Issue number8
DOIs
StatePublished - Oct 15 1994

Fingerprint

Sudden Cardiac Death
Propranolol
Cardiac Arrhythmias
Heart Diseases
Myocardial Infarction
Circadian Rhythm
Stroke Volume
Research Design
Prospective Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias. / Aronow, Wilbert S.; Ahn, Chul; Mercando, Anthony D.; Epstein, Stanley.

In: The American Journal of Cardiology, Vol. 74, No. 8, 15.10.1994, p. 819-821.

Research output: Contribution to journalArticle

@article{5c82e0c352e84290ba83ba1bc0b30991,
title = "Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias",
abstract = "Sudden cardiac death and acute myocardial infarction have a circadian pattern with a significant morning peak.1-6 The circadian rhythm associated with acute myocardial infarction was not observed in patients receiving propranolol.6 We are reporting data on the times of sudden cardiac death or fatal myocardial infarction from a prospective study of patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and a left ventricular ejection fraction ≥40{\%} randomized to propranolol or no antiarrhythmic drug.7.",
author = "Aronow, {Wilbert S.} and Chul Ahn and Mercando, {Anthony D.} and Stanley Epstein",
year = "1994",
month = "10",
day = "15",
doi = "10.1016/0002-9149(94)90445-6",
language = "English (US)",
volume = "74",
pages = "819--821",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias

AU - Aronow, Wilbert S.

AU - Ahn, Chul

AU - Mercando, Anthony D.

AU - Epstein, Stanley

PY - 1994/10/15

Y1 - 1994/10/15

N2 - Sudden cardiac death and acute myocardial infarction have a circadian pattern with a significant morning peak.1-6 The circadian rhythm associated with acute myocardial infarction was not observed in patients receiving propranolol.6 We are reporting data on the times of sudden cardiac death or fatal myocardial infarction from a prospective study of patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and a left ventricular ejection fraction ≥40% randomized to propranolol or no antiarrhythmic drug.7.

AB - Sudden cardiac death and acute myocardial infarction have a circadian pattern with a significant morning peak.1-6 The circadian rhythm associated with acute myocardial infarction was not observed in patients receiving propranolol.6 We are reporting data on the times of sudden cardiac death or fatal myocardial infarction from a prospective study of patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and a left ventricular ejection fraction ≥40% randomized to propranolol or no antiarrhythmic drug.7.

UR - http://www.scopus.com/inward/record.url?scp=0028019299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028019299&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(94)90445-6

DO - 10.1016/0002-9149(94)90445-6

M3 - Article

C2 - 7942560

AN - SCOPUS:0028019299

VL - 74

SP - 819

EP - 821

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -